Radiosurgery

• 

  Subject Areas on Research

  • 3-dimensional optimization of multiple arcs for stereotactic radiosurgery. 
  • 6D image guidance for spinal non-invasive stereotactic body radiation therapy: Comparison between ExacTrac X-ray 6D with kilo-voltage cone-beam CT. 
  • A Collimator Setting Optimization Algorithm for Dual-Arc Volumetric Modulated Arc Therapy in Pancreas Stereotactic Body Radiation Therapy. 
  • A Deep Learning-Based Computer Aided Detection (CAD) System for Difficult-to-Detect Brain Metastases. 
  • A Novel method to generate on-board 4D MRI using prior 4D MRI and on-board kV projections from a conventional LINAC for target localization in liver SBRT. 
  • A comparison of three stereotactic radiotherapy techniques; ARCS vs. noncoplanar fixed fields vs. intensity modulation. 
  • A comprehensive investigation of the accuracy and reproducibility of a multitarget single isocenter VMAT radiosurgery technique. 
  • A hypothesis: indirect cell death in the radiosurgery era. 
  • A meta-analysis comparing outcomes of microsurgery and gamma knife radiosurgery. 
  • A modern review of the uncertainties in volumetric imaging of respiratory-induced target motion in lung radiotherapy. 
  • A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. 
  • A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non-small cell lung cancer. 
  • A new treatment paradigm: neoadjuvant radiosurgery before surgical resection of brain metastases with analysis of local tumor recurrence. 
  • A pencil beam dose calculation model for CyberKnife system. 
  • A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320. 
  • A rabbit irradiation platform for outcome assessment of lung stereotactic radiosurgery. 
  • A randomized phase III trial of stereotactic radiosurgery (SRS) versus observation for patients with asymptomatic cerebral oligo-metastases in non-small-cell lung cancer. 
  • A rationale for the targeted treatment of oligometastases with radiotherapy. 
  • A review of stereotactic radiosurgery in the management of brain metastases. 
  • A review on the management of epilepsy associated with hypothalamic hamartomas. 
  • A round-robin gamma stereotactic radiosurgery dosimetry interinstitution comparison of calibration protocols. 
  • A technique of intensity-modulated radiosurgery (IMRS) for spinal tumors. 
  • A validation study of a new prognostic index for patients with brain metastases: the Graded Prognostic Assessment. 
  • Accuracy of positron emission tomography in identifying hilar (N1) lymph node involvement in non-small cell lung cancer: Implications for stereotactic body radiation therapy. 
  • Adaptive stereotactic body radiation therapy planning for lung cancer. 
  • Advances in technology for intracranial stereotactic radiosurgery. 
  • Advances in treatment techniques: arc-based and other intensity modulated therapies. 
  • Air kerma based dosimetry calibration for the Leksell Gamma Knife. 
  • Algorithms and functionality of an intensity modulated radiotherapy optimization system. 
  • Alliance A082002 -a randomized phase II/III trial of modern immunotherapy-based systemic therapy with or without SBRT for PD-L1-negative, advanced non-small cell lung cancer. 
  • Alternatives to Lobectomy for High-Risk Patients With Early-Stage Non-Small Cell Lung Cancer. 
  • An Interpretable Planning Bot for Pancreas Stereotactic Body Radiation Therapy. 
  • An investigation of machine learning methods in delta-radiomics feature analysis. 
  • Analysis of the time course of the effect of subthalamic nucleus stimulation upon hand function in Parkinson's patients. 
  • Apparatus-dependent dosimetric differences in spine stereotactic body radiotherapy. 
  • Assessing neurotoxicity from the low-dose radiation component of radiosurgery using magnetic resonance spectroscopy. 
  • Association of pre-treatment radiomic features with lung cancer recurrence following stereotactic body radiation therapy. 
  • Association of tumor genomic factors and efficacy for metastasis-directed stereotactic body radiotherapy for oligometastatic colorectal cancer. 
  • Benchmark Credentialing Results for NRG-BR001: The First National Cancer Institute-Sponsored Trial of Stereotactic Body Radiation Therapy for Multiple Metastases. 
  • Biological Principles of Stereotactic Body Radiation Therapy (SBRT) and Stereotactic Radiation Surgery (SRS): Indirect Cell Death. 
  • Biopsy of enlarging lesions after stereotactic radiosurgery for brain metastases frequently reveals radiation necrosis. 
  • Brainstem melanomas presenting as a cavernous malformation. 
  • Central nervous system cancers, version 2.2014. Featured updates to the NCCN Guidelines. 
  • Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy. 
  • Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis. 
  • Classifying Leptomeningeal Disease: An Essential Element in Managing Advanced Metastatic Disease in the Central Nervous System. 
  • Clinical and molecular markers of long-term survival after oligometastasis-directed stereotactic body radiotherapy (SBRT). 
  • Clinical commissioning and use of the Novalis Tx linear accelerator for SRS and SBRT. 
  • Clinical outcome after hypofractionated stereotactic radiotherapy (HSRT) for benign skull base tumors. 
  • Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma. 
  • Combining immunotherapy and radiotherapy for the STAR treatment. 
  • Commissioning an Exradin W2 plastic scintillation detector for clinical use in small radiation fields. 
  • Comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancer. 
  • Comparison of intensity-modulated tomotherapy with stereotactically guided conformal radiotherapy for brain tumors. 
  • Comparison of radiosurgery and conventional surgery for the treatment of glomus jugulare tumors. 
  • Concurrent stereotactic radiosurgery and bevacizumab in recurrent malignant gliomas: a prospective trial. 
  • Cone-beam-CT guided radiation therapy: A model for on-line application. 
  • Conformal radiation therapy with fixed shaped coplanar or noncoplanar radiation beam bouquets: a possible alternative to radiosurgery. 
  • Consensus Contouring Guidelines for Postoperative Completely Resected Cavity Stereotactic Radiosurgery for Brain Metastases. 
  • Cost-Effectiveness of Treatment Strategies for Spinal Metastases. 
  • Current and Emerging Surgical Therapies for Severe Pediatric Epilepsies. 
  • CyberKnife rhizotomy for facetogenic back pain: a pilot study. 
  • Cyberknife hypofractionated stereotactic radiosurgery (HSRS) of resection cavity after excision of large cerebral metastasis: efficacy and safety of an 800 cGy × 3 daily fractions regimen. 
  • Defining the optimal planning target volume in image-guided stereotactic radiosurgery of brain metastases: results of a randomized trial. 
  • Definitive Radiotherapy for Inoperable Stage IIB Non-small-cell Lung Cancer: Patterns of Care and Comparative Effectiveness. 
  • Definitive Stereotactic Body Radiotherapy (SBRT) for Extracranial Oligometastases: An International Survey of >1000 Radiation Oncologists. 
  • Delivered Dose Distribution Visualized Directly With Onboard kV-CBCT: Proof of Principle. 
  • Determining the optimal block margin on the planning target volume for extracranial stereotactic radiotherapy. 
  • Development and Assessment of a Predictive Score for Vertebral Compression Fracture After Stereotactic Body Radiation Therapy for Spinal Metastases. 
  • Development and Internal Validation of a Recursive Partitioning Analysis-Based Model Predictive of Pain Flare Incidence After Spine Stereotactic Body Radiation Therapy. 
  • Development and validation of a recursive partitioning analysis-based pretreatment decision-making tool identifying ideal candidates for spine stereotactic body radiation therapy. 
  • Divergent Interpretations of Imaging After Stereotactic Body Radiation Therapy for Lung Cancer. 
  • Dose de-escalation with gamma knife radiosurgery in the treatment of choroidal melanoma. 
  • Dosimetric Analysis of Microscopic Disease in SBRT for Lung Cancers. 
  • Dosimetric characteristics of Novalis shaped beam surgery unit. 
  • Dosimetric characteristics of novalis Tx system with high definition multileaf collimator. 
  • Dosimetric comparison of treatment plans based on free breathing, maximum, and average intensity projection CTs for lung cancer SBRT. 
  • Dosimetric effect of translational and rotational errors for patients undergoing image-guided stereotactic body radiotherapy for spinal metastases. 
  • Dosimetric effects of rotational offsets in stereotactic body radiation therapy (SBRT) for lung cancer. 
  • Dosimetric study using different leaf-width MLCs for treatment planning of dynamic conformal arcs and intensity-modulated radiosurgery. 
  • Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions. 
  • Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain Metastases. 
  • Efficacy and safety of CyberKnife radiosurgery for acromegaly. 
  • Endobronchial fiducial to guide stereotactic body radiotherapy. 
  • Evaluating radiation-induced white matter changes in patients treated with stereotactic radiosurgery using diffusion tensor imaging: a pilot study. 
  • Evaluation of Safety of Stereotactic Body Radiotherapy for the Treatment of Patients With Multiple Metastases: Findings From the NRG-BR001 Phase 1 Trial. 
  • Evaluation of dosimetric uncertainty caused by MR geometric distortion in MRI-based liver SBRT treatment planning. 
  • Evaluation of thoracic spinal cord motion using dynamic MRI. 
  • ExacTrac X-ray 6 degree-of-freedom image-guidance for intracranial non-invasive stereotactic radiotherapy: comparison with kilo-voltage cone-beam CT. 
  • Exploring the Margin Recipe for Online Adaptive Radiation Therapy for Intermediate-Risk Prostate Cancer: An Intrafractional Seminal Vesicles Motion Analysis. 
  • Extracranial radiosurgery: immobilizing liver motion in dogs using high-frequency jet ventilation and total intravenous anesthesia. 
  • Fast verification of Gamma Knifetrade mark treatment plans. 
  • Feasibility study of an intensity-modulated radiation model for the study of erectile dysfunction. 
  • Findings on Surveillance Imaging After Preoperative Partial Breast Irradiation for Early Stage Breast Cancer. 
  • First clinical retrospective investigation of limited projection CBCT for lung tumor localization in patients receiving SBRT treatment. 
  • Fitting NTCP models to SBRT dose and carotid blowout syndrome data. 
  • Fluctuating response of a cystic vestibular schwannoma to radiosurgery: case report. 
  • Frameless angiogram-based stereotactic radiosurgery for treatment of arteriovenous malformations. 
  • From active shape model to active optical flow model: a shape-based approach to predicting voxel-level dose distributions in spine SBRT. 
  • Gamma Knife radiosurgery as a primary surgical treatment for hypersecreting pituitary adenomas. 
  • Gamma Knife radiosurgery for brain metastases from gastrointestinal primary. 
  • GammaPlan-Leksell Gamma Knife radiosurgery treatment planning verification method. 
  • Helical IMRT-Based Stereotactic Body Radiation Therapy Using an Abdominal Compression Technique and Modified Fractionation Regimen for Small Hepatocellular Carcinoma. 
  • Hemorrhagic vestibular schwannoma: review of the literature. 
  • High-risk gestational trophoblastic neoplasia with brain metastases: individualized multidisciplinary therapy in the management of four patients. 
  • Hippocampal dose from stereotactic radiosurgery for 4 to 10 brain metastases: Risk factors, feasibility of dose reduction via re-optimization, and patient outcomes. 
  • How should we describe the radioblologic effect of extracranial stereotactic radlosurgery: equivalent uniform dose or tumor control probability? 
  • If at First You Don't Succeed-Stereotactic Body Radiation Therapy for Recurrent Non-Small Cell Lung Cancer. 
  • Image-guided and intensity-modulated radiosurgery for patients with spinal metastasis. 
  • Image-guided procedures for intensity-modulated spinal radiosurgery. Technical note. 
  • Image-guided radiosurgery of head and neck cancers. 
  • Immunologic Effects of Stereotactic Body Radiotherapy in Dogs with Spontaneous Tumors and the Impact of Intratumoral OX40/TLR Agonist Immunotherapy. 
  • Impact of collimator leaf width and treatment technique on stereotactic radiosurgery and radiotherapy plans for intra- and extracranial lesions. 
  • Impact of pemetrexed on intracranial disease control and radiation necrosis in patients with brain metastases from non-small cell lung cancer receiving stereotactic radiation. 
  • Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial. 
  • Improving Quality and Consistency in NRG Oncology Radiation Therapy Oncology Group 0631 for Spine Radiosurgery via Knowledge-Based Planning. 
  • In Regard to Churilla et al. 
  • In Reply to Giron et al. 
  • In regard to Yamamoto et al. 
  • In reply to Kumar et al. 
  • In reply to Robins et al. 
  • Indirect Tumor Cell Death After High-Dose Hypofractionated Irradiation: Implications for Stereotactic Body Radiation Therapy and Stereotactic Radiation Surgery. 
  • Integration of cone-beam CT in stereotactic body radiation therapy. 
  • Intensity-modulated stereotactic radiosurgery using dynamic micro-multileaf collimation. 
  • Intervention for unruptured high-grade intracranial dural arteriovenous fistulas: a multicenter study. 
  • Intracranial and Extracranial Progression and Their Correlation With Overall Survival After Stereotactic Radiosurgery in a Multi-institutional Cohort With Brain Metastases. 
  • Intractable epilepsy following radiosurgery for arteriovenous malformation. 
  • Intraoperative dynamic MRI: localization of sites of brain tumor recurrence after high-dose radiotherapy. 
  • Investigating the accuracy of microstereotactic-body-radiotherapy utilizing anatomically accurate 3D printed rodent-morphic dosimeters. 
  • Irradiation and immunotherapy: From concept to the clinic. 
  • Is a single isocenter sufficient for volumetric modulated arc therapy radiosurgery when multiple itracranial metastases are spatially dispersed? 
  • LINAC based stereotactic radiosurgery for multiple brain metastases: guidance for clinical implementation. 
  • Leptomeningeal failure in patients with breast cancer receiving stereotactic radiosurgery for brain metastases. 
  • Letter to the editor in response to German et al. Stereotactic radiosurgery for vestibular schwannomas: a survey of current practice patterns of neurotologists. 
  • Local Tumor Control and Patient Outcome Using Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: iRECIST as a Potential Substitute for Traditional Criteria. 
  • Local control and results of Leksell Gamma Knife therapy for the treatment of uveal melanoma. 
  • MRI-based treatment planning for liver stereotactic body radiotherapy: validation of a deep learning-based synthetic CT generation method. 
  • Maximizing Tumor Control and Limiting Complications With Stereotactic Body Radiation Therapy for Pancreatic Cancer. 
  • Metastatic Renal Cell Carcinoma to the Spine: Outcomes and Morbidity: Single-Center Experience. 
  • Microsurgery vs gamma knife radiosurgery for the treatment of vestibular schwannomas. 
  • Morphology-guided radiosurgery treatment planning and optimization for multiple isocenters. 
  • Multisession CyberKnife radiosurgery for intramedullary spinal cord arteriovenous malformations. 
  • No free lunch: secondary neoplasms after stereotactic radiation. 
  • Nomogram Predicting Overall Survival Benefit of Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer. 
  • Noninvasive Thalamotomy for Refractory Tremor by Frameless Radiosurgery. 
  • Novalis radiosurgery for metastatic spine tumors. 
  • Offer Hypofractionated SRS… If Her Performance Status Is Good. 
  • Oligometastatic breast cancer: where are we now and where are we headed?-a narrative review. 
  • Oligoreview of Non-Small Cell Lung Cancer Oligometastases. 
  • Omitting radiosurgery in melanoma brain metastases: a drastic and dangerous de-escalation. 
  • Opportunities for Radiosensitization in the Stereotactic Body Radiation Therapy (SBRT) Era. 
  • Orbital Metastasis of Undifferentiated/Anaplastic Thyroid Carcinoma. 
  • Organs at Risk Considerations for Thoracic Stereotactic Body Radiation Therapy: What Is Safe for Lung Parenchyma? 
  • Overview of stereotactic body radiotherapy and the nursing role. 
  • Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. 
  • Phase II study of stereotactic radiosurgery for the treatment of patients with oligoprogression on erlotinib. 
  • Physics and imaging for targeting of oligometastases. 
  • Physics considerations for single-isocenter, volumetric modulated arc radiosurgery for treatment of multiple intracranial targets. 
  • Pituitary adenomas: the effect of gamma knife radiosurgery on tumor growth and endocrinopathies. 
  • Plug pattern optimization for gamma knife radiosurgery treatment planning. 
  • Point dose verification for intensity modulated radiosurgery using Clarkson's method. 
  • Point/Counterpoint. A 3D-conformal technique is better than IMRT or VMAT for lung SBRT. 
  • Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non-small cell lung cancer. 
  • Postoperative radiosurgery for malignant spinal tumors. 
  • Predicting the effect of temporal variations in PO2 on tumor radiosensitivity. 
  • Predictors of vestibular schwannoma growth and clinical implications. 
  • Predominance of Spinal Metastases Involving the Posterior Vertebral Body. 
  • Preoperative single fraction partial breast radiotherapy for early-stage breast cancer. 
  • Pretreatment 18F-Fluorodeoxyglucose Positron Emission Tomography Standardized Uptake Values and Tumor Size in Medically Inoperable Nonsmall Cell Lung Cancer Is Prognostic of Overall 2-Year Survival After Stereotactic Body Radiation Therapy. 
  • Prognostic models for patients with brain metastases after stereotactic radiosurgery with or without whole brain radiotherapy: a validation study. 
  • Proton Therapy for Brain Metastases: A Question of Value. 
  • Pulmonary function testing after stereotactic body radiotherapy to the lung. 
  • Quantification and minimization of uncertainties of internal target volume for stereotactic body radiation therapy of lung cancer. 
  • Quantifying the impact of SpaceOAR hydrogel on inter-fractional rectal and bladder dose during 0.35 T MR-guided prostate adaptive radiotherapy. 
  • RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1-3) spine metastases: phase 2 results. 
  • Radiation dose-volume effects in the brain. 
  • Radiation dose-volume effects in the spinal cord. 
  • Radiation dose-volume effects of optic nerves and chiasm. 
  • Radiation therapy for oligometastatic non-small cell lung cancer. 
  • Radiation-induced lung damage in patients treated with stereotactic body radiotherapy after EGFR-TKIs: is there any difference from stereotactic body radiotherapy alone? 
  • Radical irradiation of extracranial oligometastases. 
  • Radiobiological basis of SBRT and SRS. 
  • Radiofrequency catheter ablation for the treatment of human type 1 atrial flutter. Identification of a critical zone in the reentrant circuit by endocardial mapping techniques. 
  • Radiology quiz case 2. Docetaxel (Taxotere)-induced photosensitivity. 
  • Radiosurgery for Treatment of Renal Cell Metastases to Spine: A Systematic Review of the Literature. 
  • Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method. 
  • Radiosurgery in the treatment of spinal metastases: tumor control, survival, and quality of life after helical tomotherapy. 
  • Radiosurgery is not "standard of care" for solitary brain metastases: regarding Flickinger et al., IJROBP 28:797-802; 1994. 
  • Radiosurgery treatment planning using conformal arc informed volumetric modulated arc therapy. 
  • Radiosurgery, cost-effectiveness, gold standards, the scientific method, cavalier cowboys, and the cost of hope. 
  • Radiosurgical treatment for Ewing's sarcoma of the lumbar spine: case report. 
  • Radiotherapy and radiosurgery for tumors of the central nervous system. 
  • Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases. 
  • Re-examining TG-142 recommendations in light of modern techniques for linear accelerator based radiosurgery. 
  • Real-time inverse planning for Gamma Knife radiosurgery. 
  • Recommendations on the practice of calibration, dosimetry, and quality assurance for gamma stereotactic radiosurgery: Report of AAPM Task Group 178. 
  • Recurrent intracranial Masson's vegetant intravascular hemangioendothelioma. Case report and review of the literature. 
  • Recurrent malignant gliomas. 
  • Refinement of treatment setup and target localization accuracy using three-dimensional cone-beam computed tomography for stereotactic body radiotherapy. 
  • Reirradiation for recurrent head and neck cancer. 
  • Reproducibility of tumor motion probability distribution function in stereotactic body radiation therapy of lung cancer. 
  • Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma. 
  • Retrospective clinicopathologic correlation of gross tumor size of hepatocellular carcinoma: implications for stereotactic body radiotherapy. 
  • Retrospective quality metrics review of stereotactic radiosurgery plans treating multiple targets using single-isocenter volumetric modulated arc therapy. 
  • Review of stereotactic radiosurgery for intradural spine tumors. 
  • Risk calculators are useful but.... 
  • Role of stereotactic body radiotherapy in gynecologic radiation oncology. 
  • SAbR as an Alternative Boost Modality for Cervical Cancer: A Cautionary Exercise. 
  • Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial. 
  • Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas. 
  • Salvage Radiotherapy for Nodal Oligorecurrent Prostate Cancer: A Step Towards Predictive Criteria for Metastasis-Directed Therapy in Prostate Cancer? 
  • Secondary analysis of RTOG 9508, a phase 3 randomized trial of whole-brain radiation therapy versus WBRT plus stereotactic radiosurgery in patients with 1-3 brain metastases; poststratified by the graded prognostic assessment (GPA). 
  • Selection of treatment modalities or observation of arteriovenous malformations. 
  • Sensitivity of 3D Dose Verification to Multileaf Collimator Misalignments in Stereotactic Body Radiation Therapy of Spinal Tumor. 
  • Simple Factors Associated With Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy of the Thorax: A Pooled Analysis of 88 Studies. 
  • Single institution's dosimetry and IGRT analysis of prostate SBRT. 
  • Single isocenter SRS using CAVMAT offers improved robustness to commissioning and treatment delivery uncertainty compared to VMAT. 
  • Single- and Multi-Fraction Stereotactic Radiosurgery Dose Tolerances of the Optic Pathways. 
  • Single-fraction SBRT for Early Stage NSCLC-A Viable Option in "These Uncertain Times"? 
  • Sintilimab, stereotactic body radiotherapy and granulocyte-macrophage colony stimulating factor as second-line therapy for advanced non-small cell lung cancer: safety run-in results of a multicenter, single-arm, phase II trial. 
  • Spinal metastases 2021: a review of the current state of the art and future directions. 
  • Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current State and Future Opportunities. 
  • Stereotactic Body Radiation Therapy-Induced Abscopal Effect on Hepatocellular Carcinoma After Treatment for Lung Cancer: A Case Report. 
  • Stereotactic Body Radiotherapy Versus Delayed Surgery for Early-stage Non-small-cell Lung Cancer. 
  • Stereotactic Body Radiotherapy for Oligometastasis: Opportunities for Biology to Guide Clinical Management. 
  • Stereotactic Laser Ablation (SLA) followed by consolidation stereotactic radiosurgery (cSRS) as treatment for brain metastasis that recurred locally after initial radiosurgery (BMRS): a multi-institutional experience. 
  • Stereotactic Radiosurgery for Resected Brain Metastases: New Evidence Supports a Practice Shift, but Questions Remain. 
  • Stereotactic Radiosurgery for Vestibular Schwannomas: Tumor Control Probability Analyses and Recommended Reporting Standards. 
  • Stereotactic body radiation therapy for curative treatment of adrenal metastases. 
  • Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline. 
  • Stereotactic body radiation therapy for treatment of primary and metastatic pulmonary malignancies. 
  • Stereotactic body radiation therapy versus sublobar resection for stage I NSCLC. 
  • Stereotactic body radiation therapy: the report of AAPM Task Group 101. 
  • Stereotactic body radiotherapy for lesions of the spine and paraspinal regions. 
  • Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease. 
  • Stereotactic body radiotherapy for oligometastatic breast cancer: a new standard of care, or a medical reversal in waiting? 
  • Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma. 
  • Stereotactic body radiotherapy in patients with stage I non-small-cell lung cancer aged 75 years and older: retrospective results from a multicenter consortium. 
  • Stereotactic body radiotherapy reirradiation for recurrent epidural spinal metastases. 
  • Stereotactic body radiotherapy treatment of extracranial metastases. 
  • Stereotactic body radiotherapy: a critical review for nonradiation oncologists. 
  • Stereotactic radiosurgery and bevacizumab for recurrent glioblastoma multiforme. 
  • Stereotactic radiosurgery for recurrent malignant gliomas. 
  • Stereotactic radiosurgery for recurrent pediatric brain tumors: clinical outcomes and toxicity. 
  • Stereotactic radiosurgery in pediatric patients. 
  • Stereotactic radiosurgery in the management of brain metastases from primary thyroid cancers. 
  • Stereotactic radiosurgery in the treatment of a dural carotid-cavernous fistula. 
  • Stereotactic radiosurgery in the treatment of primary central nervous system lymphoma. 
  • Stereotactic radiosurgery versus surgical resection for spinal hemangioblastoma: A systematic review. 
  • Stereotactic radiotherapy for malignancies involving the trigeminal and facial nerves. 
  • Stereotactic radiotherapy for pancreatic cancer? 
  • Stereotactic radiotherapy for pulmonary metastases. 
  • Stereotactic radiotherapy for trigeminal schwannomas. 
  • Surgery versus SABR for resectable non-small-cell lung cancer. 
  • Surgery versus stereotactic body radiation therapy for operable stage I non-small cell lung cancer: Can we achieve equipoise? 
  • Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: A comprehensive review. 
  • Surgical Evaluation in Patients Undergoing Radiation Therapy for Early-Stage Lung Cancer. 
  • Surgical Treatment of Parkinson Disease. 
  • Surgical management of nonvascular lesions around the oculomotor nerve. 
  • Surgical management of vestibular schwannomas after failed radiation treatment. 
  • Systematic Review and Meta-analysis for Surgery Versus Stereotactic Radiosurgery for Jugular Paragangliomas. 
  • Targeted radiotherapy for malignant gliomas. 
  • Technical Note: Imaging dose resulting from optimized procedures with limited-angle intrafractional verification system during stereotactic body radiation therapy lung treatment. 
  • The Effect of Various Dose Normalization Strategies When Implementing Linear Boltzmann Transport Equation Dose Calculation for Lung Stereotactic Body Radiation Therapy Planning. 
  • The best that surgery has to offer. 
  • The effect of detector size to the broadening of the penumbra--a computer simulated study. 
  • The evolving role of radiotherapy in treatment of oligometastatic NSCLC. 
  • The evolving role of stereotactic radiosurgery and stereotactic radiation therapy for patients with spine tumors. 
  • The expanding role of stereotactic body radiation therapy in oligometastatic solid tumors: What do we know and where are we going? 
  • The impact of respiratory motion and treatment technique on stereotactic body radiation therapy for liver cancer. 
  • The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. 
  • The oligometastatic state - separating truth from wishful thinking. 
  • The radiosurgery fractionation quandary: single fraction or hypofractionation? 
  • The role of surgery and ablative radiotherapy in oligometastatic breast cancer. 
  • The use of six degrees of freedom couch is only clinically beneficial in stereotactic radio surgery. 
  • The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study. 
  • Thoracic Radiotherapy for Renal Cell Carcinoma Metastases: Local Control for the Management of Lung and Mediastinal Disease in the Modern Era. 
  • Three-dimensional skeletonization for computer-assisted treatment planning in radiosurgery. 
  • Time to Steroid Independence After Laser Interstitial Thermal Therapy vs Medical Management for Treatment of Biopsy-Proven Radiation Necrosis Secondary to Stereotactic Radiosurgery for Brain Metastasis. 
  • Timing of surgery and radiotherapy in the management of metastatic spine disease: a systematic review. 
  • Tissue engineered cancer metastases as cancer vaccine to improve cancer immunotherapy. 
  • Toward acquiring comprehensive radiosurgery field commissioning data using the PRESAGE/optical-CT 3D dosimetry system. 
  • Toxicity and quality of life report of a phase II study of stereotactic body radiotherapy (SBRT) for low and intermediate risk prostate cancer. 
  • Transfer learning for fluence map prediction in adrenal stereotactic body radiation therapy. 
  • Treatment of Thymoma-Associated Myasthenia Gravis With Stereotactic Body Radiotherapy: A Case Report. 
  • Trends in surgical use and associated patient outcomes in the treatment of acoustic neuroma. 
  • Triphasic contrast enhanced CT simulation with bolus tracking for pancreas SBRT target delineation. 
  • Tumor cells, but not endothelial cells, mediate eradication of primary sarcomas by stereotactic body radiation therapy. 
  • Tumor necrosis and cavitation after stereotactic body radiation therapy. 
  • Twenty-year survival in glioblastoma: a case report and molecular profile. 
  • Uncertainties in the dosimetric heterogeneity correction and its potential effect on local control in lung SBRT. 
  • Use of the BrainLAB ExacTrac X-Ray 6D system in image-guided radiotherapy. 
  • Value of Neoadjuvant Radiation Therapy in the Management of Pancreatic Adenocarcinoma. 
  • Volumetric arc intensity-modulated therapy for spine body radiotherapy: comparison with static intensity-modulated treatment. 
  • When is a biopsy-proven diagnosis necessary before stereotactic ablative radiotherapy for lung cancer?: A decision analysis. 
  • Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. 
• 

  Keywords of People

  • Buckley, Anne Frances, Assistant Professor of Pathology, Pathology
  • Craciunescu, Oana, Professor of Radiation Oncology, Radiation Oncology
  • Kim, Grace Jewel, Assistant Professor of Radiation Oncology, Radiation Oncology
  • O'Daniel, Jennifer Colleen, Assistant Professor of Radiation Oncology, Radiation Oncology
  • Sampson, John Howard, Robert H., M.D. and Gloria Wilkins Professor of Neurosurgery, in the School of Medicine, Biomedical Engineering
  • Wu, Qingrong, Professor of Radiation Oncology, Radiation Oncology